Theriva Biologics Inc Com Par $.001 Gains 35.71%
Fri, Sep 06, 2024 at 07:33 PM
Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT) rocketted at $4.37, a gain of 35.7%. The stock got featured on our News Catalysts scanner on Mon, Aug 26, 2024 at 12:03 PM in the 'SPLIT' category. From Fri, Aug 23, 2024, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Fri, Aug 30, 2024 at $7.15 with a volume of 26M+.
About Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT)
Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics.
Top 10 Gainers:
- ARCA biopharma, Inc. (ABIO:NASDAQ), 1052%
- BloomZ Inc. (BLMZ:NASDAQ), 119.06%
- Ryde Group Ltd. Class A (RYDE:NYSEMKT), 42.75%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 39.41%
- Solarmax Technology Inc. (SMXT:NASDAQ), 39.25%
- Beneficient (BENF:NASDAQ), 36.67%
- Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 35.71%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 31.1%
- Argan, Inc. (AGX:NYSE), 26.04%
- Primega Group Holdings Limited (PGHL:NASDAQ), 25.67%